Replies to post #17834 on Innovation Pharmaceuticals Inc (IPIX)

[TheProgressive]

Very well said, this sums it up nicely

[umiak]

CTIX-The question remains what is a biologic worth that is well tolerated
and shrinks multiple types of cancer? (in humans) My guess is multi-mulit
billion.

A doubling of the dose on 2nd cohort bodes well for tolerability,
what is the value of early signs of safety in what is to cancer
what penicillin was to bacterial infection?

To help put this in perspective Xalkori is a biologic that treats 10%
of 40% of all lung cancers, 60% of these patients experience tumor
shrinkage with few side effects. As small as this population is the
drug is 1.5B sales estimate.

Multiply 50% of ALL lung, breast, liver and prostate cancers times
multi-billion to even start to see the potential of kevertrin.